SCHEMBL10179957

SCHEMBL10179957

COCc1c(-c2nc(-c3cccc(CN4CCN(C)CC4)c3)no2)nnn1-c1ccccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
GLA P06280 1/20 0.43
HSD17B10 Q99714 1/20 0.43
S1PR1 P21453 3/20 0.42
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HIF1A Q16665 1/20 0.39
MAPT P10636 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 4/20 0.38
CES2 O00748 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
HTR1A P08908 1/20 0.37
DRD2 P14416 1/20 0.37
CYP2D6 P10635 1/20 0.37
KCNH2 Q12809 1/20 0.37
ACHE P22303 1/20 0.36
KDR P35968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10179370 0.83 CYP19A1 (0.42) ALDH1A1S1PR1MAPTSMN1; SMN2TP53
SCHEMBL3763187 0.83 MAPT (0.49) ALDH1A1S1PR1CASP1CASP7MAPT
SCHEMBL10180292 0.82 TP53 (0.54) ALDH1A1HSD17B10MAPTSMN1; SMN2TP53
SCHEMBL3455783 0.80 TP53 (0.43) ALDH1A1GLAHSD17B10S1PR1MAPT
SCHEMBL3748432 0.79 S1PR1 (0.55) ALDH1A1GLAHSD17B10S1PR1MAPT
SCHEMBL3753146 0.79 CA9 (0.50) S1PR1MAPTTP53RXFP1NPC1
SCHEMBL10181578 0.79 MAPT (0.53) ALDH1A1GLAHSD17B10S1PR1MAPT
SCHEMBL10179953 0.78 RAB9A (0.47) HSD17B10S1PR1MAPTSMN1; SMN2TP53
SCHEMBL10181600 0.78 S1PR1 (0.48) ALDH1A1GLAHSD17B10S1PR1MAPT
SCHEMBL3760886 0.78 PPARA (0.45) ALDH1A1HSD17B10S1PR1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8202856-B2 Triazole oxadiazoles derivatives MERCK SERONO SA (CH) 2012-06-19 US disclosed
US-8202856-B2 Triazole oxadiazoles derivatives MERCK SERONO SA (CH) 2012-06-19 US disclosed
US-20100305092-A1 TRIAZOLE OXADIAZOLES DERIVATIVES MERCK SERONO SA (CH) 2010-12-02 US disclosed
US-20100305092-A1 TRIAZOLE OXADIAZOLES DERIVATIVES MERCK SERONO SA (CH) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305092-A1 TRIAZOLE OXADIAZOLES DERIVATIVES OXA1L, RO60, PDCD11 ALDH1A1 466/4885GLA 3420/4885HSD17B10 2924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.